Rethinking ovarian cancer: recommendations for improving outcomes.


Autoria(s): Vaughan S.; Coward J.I.; Bast R.C.; Berchuck A.; Berek J.S.; Brenton J.D.; Coukos G.; Crum C.C.; Drapkin R.; Etemadmoghadam D.; Friedlander M.; Gabra H.; Kaye S.B.; Lord C.J.; Lengyel E.; Levine D.A.; McNeish I.A.; Menon U.; Mills G.B.; Nephew K.P.; Oza A.M.; Sood A.K.; Stronach E.A.; Walczak H.; Bowtell D.D.; Balkwill F.R.
Data(s)

2011

Resumo

There have been major advances in our understanding of the cellular and molecular biology of the human malignancies that are collectively referred to as ovarian cancer. At a recent Helene Harris Memorial Trust meeting, an international group of researchers considered actions that should be taken to improve the outcome for women with ovarian cancer. Nine major recommendations are outlined in this Opinion article.

Identificador

http://serval.unil.ch/?id=serval:BIB_A9507A5CA56B

isbn:1474-1768 (Electronic)

pmid:21941283

doi:10.1038/nrc3144

isiid:000295155600011

Idioma(s)

en

Fonte

Nature Reviews. Cancer, vol. 11, no. 10, pp. 719-725

Palavras-Chave #Animals; Antineoplastic Agents/therapeutic use; Clinical Trials as Topic; Female; Health Planning Guidelines; Humans; Ovarian Neoplasms/drug therapy; Ovarian Neoplasms/genetics; Practice Guidelines as Topic; Treatment Outcome
Tipo

info:eu-repo/semantics/review

article